Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1077199

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Insurance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to bring forward legislative proposal for a state-backed indemnity scheme for health care professionals.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	225395
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>The National Health Service (Clinical Negligence Scheme for General Practice) Regulations 2019 were laid in parliament on 25 February 2019 and come into force on 1 April 2019. The Regulations establish a scheme which provides indemnity cover for future clinical negligence liabilities of general practitioners, and others working in general practice in respect of services provided as part of the National Health Service in England.</p><p> </p><p>The Department also intends to establish the arrangements for an existing liabilities scheme in April 2019, subject to satisfactory discussions with the Medical Defence Organisations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2019 16:22:50 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1077200

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	UK Antimicrobial Resistance Diagnostics Collaborative
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 February 2019 to Question 219373 on UK Antimicrobial Resistance Diagnostics Collaborative, what representations his Department has received from members of that Collaborative; if he will publish the names of its members; and whether a Chair of that Collaborative has been appointed.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	225396
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>NHS England established the United Kingdom Antimicrobial Resistance (AMR) Diagnostics Collaborative in 2018 to deliver the UK’s diagnostic ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostic elements of the new five-year UK AMR national action plan, published in January this year.</p><p> </p><p>The work of the Collaborative contributes directly to the Government’s commitments on AMR, and the Collaborative’s secretariat communicates with the Department on a regular basis and it has been represented by its secretariat and former chair in the UK AMR Programme’s governance groups.</p><p> </p><p>The Collaborative’s chair remains vacant while NHS England develops detailed plans to support the implementation of the new national plan on AMR. As part of this work, the membership of the Collaborative is under review.</p><p> </p><p>Current membership is drawn from a range of stakeholders across Government and its agencies, the devolved administrations, the health system, veterinary medicine, professional bodies, academia, the research community and industry. Members at or above ‘very senior manager’ (VSM) level and partner agencies involved in the Collaborative are listed in the following table.</p><table><tbody><tr><td><p>Members of the UK Antimicrobial Resistance Diagnostics Collaborative at or above VSM level</p></td><td><p>Organisation</p></td></tr><tr><td><p>Mohamed Sadak</p></td><td><p>Health Education England</p></td></tr><tr><td><p>Marion Lyons</p></td><td><p>Welsh Government</p></td></tr><tr><td><p>Gerry Waldron</p></td><td><p>Public Health Agency Northern Ireland</p></td></tr><tr><td><p>Neil Woodford</p></td><td><p>Public Health England</p></td></tr><tr><td colspan="2"><p>Partner Agencies</p></td></tr><tr><td><p>NHS Scotland</p></td><td><p>NHS England</p></td></tr><tr><td><p>NHS Sheffield Clinical Commissioning Group</p></td><td><p>Department of Health and Social Care</p></td></tr><tr><td><p>NHS Improvement</p></td><td><p>University of Bristol</p></td></tr><tr><td><p>Institute of Biomedical Science</p></td><td><p>Association of Clinical Biochemistry and Laboratory Medicine</p></td></tr><tr><td><p>UK Standards for Microbiology Investigations</p></td><td><p>Royal College of Pathology</p></td></tr><tr><td><p>Royal College of General Practice</p></td><td><p>National Institute for Health and Care Excellence (NICE) Medical Technology Guidance</p></td></tr><tr><td><p>Sherwood Forrest NHS Foundation Trust</p></td><td><p>Royal College of Nursing</p></td></tr><tr><td><p>University of Surrey</p></td><td><p>Addenbrookes Hospital NHS Trust</p></td></tr><tr><td><p>University of Edinburgh</p></td><td><p>Medical Research Council</p></td></tr><tr><td><p>British In Vitro Diagnostic Association</p></td><td><p>NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative</p></td></tr><tr><td><p>Innovate UK</p></td><td><p>NICE</p></td></tr><tr><td><p>Royal Cornwall Hospital</p></td><td><p>Kingston University</p></td></tr><tr><td><p>Department for Environment, Food and Rural Affairs</p></td><td><p>Responsible Use of Medicines in Agriculture Alliance</p></td></tr><tr><td><p>University of Liverpool</p></td><td><p>Ulster University</p></td></tr><tr><td><p>University of Exeter</p></td><td><p>Westpoint Farm Vets</p></td></tr><tr><td><p>University of Nottingham</p></td><td><p>Centre for Ecology and Hydrology</p></td></tr><tr><td><p>Cardiff University</p></td><td><p>Guy’s and St Thomas’ Hospital NHS Foundation Trust</p></td></tr><tr><td><p>Glasgow Caledonian University</p></td><td><p> </p></td></tr></tbody></table> answering member constituency Winchester answering member printed Steve Brine question first answered 21/03/2019 16:10:43 answering member 4067 label Biography information for Steve Brine previous answer version 105072 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1059887

registered interest
date	12/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how has the £300 million per year to fund new diagnostic equipment and additional staff capacity announced in the 2015 Comprehensive Spending Review has been allocated.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	220081
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>The 2015 Comprehensive Spending Review made a commitment to invest up to £300 million per year by 2020/21. The published financial profile agreed for the NHS England Cancer Programme over the four years to 2020/21 was:</p><p> </p><table><tbody><tr><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td></tr><tr><td><p>£123 million</p></td><td><p>£140 million</p></td><td><p>£154 million</p></td><td><p>£190 million</p></td></tr></tbody></table><p> </p><p>This is being invested in earlier diagnosis and personalised care, including additional staff capacity and equipment. In addition, £130 million has been invested to modernise radiotherapy equipment. Funding has been allocated for over 80 new or upgraded linear accelerators across the country since October 2016.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:22:47 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1058800

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of nationally commissioning more public health services through community pharmacy.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	219278
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.</p><p>An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf</a></p><p>A small proportion of the pharmacies eligible for the scheme will not receive a payment because they do not meet the payment criteria as set out in the Drug Tariff. This means their income in 2016/17 is greater than their 2015/16 income less a 1% efficiency saving, and/or their estimated income in 2017/18 and 2018/19 is greater than their 2015/16 income less a 3% efficiency saving. The number and proportion of pharmacies on the scheme in receipt of a payment, for each year that the scheme has been running, is set out in the following table.</p><table><tbody><tr><td><p> </p></td><td><p>Total number of eligible pharmacies</p></td><td><p>Total number of pharmacies receiving zero payments</p></td><td><p>Total number of pharmacies in receipt of payment</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,402</p></td><td><p>47 (3%)</p></td><td><p>1,355 (97%)</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,415<sup><sup>[1]</sup></sup></p></td><td><p>57 (4%)</p></td><td><p>1,358 (96%)</p></td></tr></tbody></table><p><sup><sup><br>[1]</sup></sup>Two additional pharmacies have been accepted on to the scheme since the publication of the updated list. This explains the difference in the figures of 1,413 and 1,415 for 2017/18.</p><p>The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs’ bill.</p><p>Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.</p><table><tbody><tr><td><p>Time period</p></td><td><p>Total essential services funding<sup>2</sup> /£</p></td><td><p>Total national CPCF funding (essential and advanced services) less medicines margin/ £</p></td><td><p>Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %</p></td></tr><tr><td><p>2015/16</p></td><td><p>1,881,828,149</p></td><td><p>2,000,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,769,216,586</p></td><td><p>1,887,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,668,141,583</p></td><td><p>1,792,000,000</p></td><td><p>93</p></td></tr></tbody></table><p><sup><br>2</sup>This comprises the fees and allowances paid under Part IIIA: Professional Fees (Pharmacy Contractors) and Part VIA: Payment for Essential Services (Pharmacy Contractors) of the Drug Tariff, and through the Quality Payment Scheme and Pharmacy Access Scheme. This does not include medicines margin.</p><p>Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219279 219280 219281 question first answered 14/02/2019 17:46:27 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1058801

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will list each pharmacy in receipt of funding from the Pharmacy Access Scheme in each year since the establishment of that scheme.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	219279
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.</p><p>An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf</a></p><p>A small proportion of the pharmacies eligible for the scheme will not receive a payment because they do not meet the payment criteria as set out in the Drug Tariff. This means their income in 2016/17 is greater than their 2015/16 income less a 1% efficiency saving, and/or their estimated income in 2017/18 and 2018/19 is greater than their 2015/16 income less a 3% efficiency saving. The number and proportion of pharmacies on the scheme in receipt of a payment, for each year that the scheme has been running, is set out in the following table.</p><table><tbody><tr><td><p> </p></td><td><p>Total number of eligible pharmacies</p></td><td><p>Total number of pharmacies receiving zero payments</p></td><td><p>Total number of pharmacies in receipt of payment</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,402</p></td><td><p>47 (3%)</p></td><td><p>1,355 (97%)</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,415<sup><sup>[1]</sup></sup></p></td><td><p>57 (4%)</p></td><td><p>1,358 (96%)</p></td></tr></tbody></table><p><sup><sup><br>[1]</sup></sup>Two additional pharmacies have been accepted on to the scheme since the publication of the updated list. This explains the difference in the figures of 1,413 and 1,415 for 2017/18.</p><p>The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs’ bill.</p><p>Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.</p><table><tbody><tr><td><p>Time period</p></td><td><p>Total essential services funding<sup>2</sup> /£</p></td><td><p>Total national CPCF funding (essential and advanced services) less medicines margin/ £</p></td><td><p>Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %</p></td></tr><tr><td><p>2015/16</p></td><td><p>1,881,828,149</p></td><td><p>2,000,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,769,216,586</p></td><td><p>1,887,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,668,141,583</p></td><td><p>1,792,000,000</p></td><td><p>93</p></td></tr></tbody></table><p><sup><br>2</sup>This comprises the fees and allowances paid under Part IIIA: Professional Fees (Pharmacy Contractors) and Part VIA: Payment for Essential Services (Pharmacy Contractors) of the Drug Tariff, and through the Quality Payment Scheme and Pharmacy Access Scheme. This does not include medicines margin.</p><p>Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219278 219280 219281 question first answered 14/02/2019 17:46:27 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1058802

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much and proportion of pharmacy funding has been spent on (a) dispensing and (b) enhanced services in each year since 2015-16.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	219280
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.</p><p>An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf</a></p><p>A small proportion of the pharmacies eligible for the scheme will not receive a payment because they do not meet the payment criteria as set out in the Drug Tariff. This means their income in 2016/17 is greater than their 2015/16 income less a 1% efficiency saving, and/or their estimated income in 2017/18 and 2018/19 is greater than their 2015/16 income less a 3% efficiency saving. The number and proportion of pharmacies on the scheme in receipt of a payment, for each year that the scheme has been running, is set out in the following table.</p><table><tbody><tr><td><p> </p></td><td><p>Total number of eligible pharmacies</p></td><td><p>Total number of pharmacies receiving zero payments</p></td><td><p>Total number of pharmacies in receipt of payment</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,402</p></td><td><p>47 (3%)</p></td><td><p>1,355 (97%)</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,415<sup><sup>[1]</sup></sup></p></td><td><p>57 (4%)</p></td><td><p>1,358 (96%)</p></td></tr></tbody></table><p><sup><sup><br>[1]</sup></sup>Two additional pharmacies have been accepted on to the scheme since the publication of the updated list. This explains the difference in the figures of 1,413 and 1,415 for 2017/18.</p><p>The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs’ bill.</p><p>Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.</p><table><tbody><tr><td><p>Time period</p></td><td><p>Total essential services funding<sup>2</sup> /£</p></td><td><p>Total national CPCF funding (essential and advanced services) less medicines margin/ £</p></td><td><p>Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %</p></td></tr><tr><td><p>2015/16</p></td><td><p>1,881,828,149</p></td><td><p>2,000,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,769,216,586</p></td><td><p>1,887,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,668,141,583</p></td><td><p>1,792,000,000</p></td><td><p>93</p></td></tr></tbody></table><p><sup><br>2</sup>This comprises the fees and allowances paid under Part IIIA: Professional Fees (Pharmacy Contractors) and Part VIA: Payment for Essential Services (Pharmacy Contractors) of the Drug Tariff, and through the Quality Payment Scheme and Pharmacy Access Scheme. This does not include medicines margin.</p><p>Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219278 219279 219281 question first answered 14/02/2019 17:46:27 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1058803

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps are being taken to (a) increase medicines adherence for repeat prescriptions and (b) reduce medicines wastage from repeat prescriptions.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	219281
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The Government has been clear that it wants to change the focus of the health and care system onto prevention and Ministers have also set out an ambition for local pharmacies to play a stronger role in helping people stay well in the community. The Department has committed to publishing a Green Paper on prevention that will set out how these plans will be achieved in more detail. An assessment specifically focusing on the potential merits of nationally commissioning more public health services through community pharmacy has not been undertaken.</p><p>An updated list of the 1,413 pharmacies found to be eligible for the pharmacy access scheme was published in January 2018, this is publicly available and can be found at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/670305/PhAS_List_20122017_updated.pdf</a></p><p>A small proportion of the pharmacies eligible for the scheme will not receive a payment because they do not meet the payment criteria as set out in the Drug Tariff. This means their income in 2016/17 is greater than their 2015/16 income less a 1% efficiency saving, and/or their estimated income in 2017/18 and 2018/19 is greater than their 2015/16 income less a 3% efficiency saving. The number and proportion of pharmacies on the scheme in receipt of a payment, for each year that the scheme has been running, is set out in the following table.</p><table><tbody><tr><td><p> </p></td><td><p>Total number of eligible pharmacies</p></td><td><p>Total number of pharmacies receiving zero payments</p></td><td><p>Total number of pharmacies in receipt of payment</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,402</p></td><td><p>47 (3%)</p></td><td><p>1,355 (97%)</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,415<sup><sup>[1]</sup></sup></p></td><td><p>57 (4%)</p></td><td><p>1,358 (96%)</p></td></tr></tbody></table><p><sup><sup><br>[1]</sup></sup>Two additional pharmacies have been accepted on to the scheme since the publication of the updated list. This explains the difference in the figures of 1,413 and 1,415 for 2017/18.</p><p>The fees and allowances paid under the Community Pharmacy Contractual Framework (CPCF) for the provision of essential services, including dispensing, provided by community pharmacies each year from April 2015 to March 2018 are detailed in the following table, based on data provided by NHS England. The structure of fees and allowances does not allow payments just for dispensing to be isolated. These payments do not include the medicine margin that community pharmacies earn as part of the payment for essential services, which is paid through reimbursement within the drugs’ bill.</p><p>Enhanced services are locally commissioned. As such they are funded outside of the national CPCF and the Department does not hold the information sought.</p><table><tbody><tr><td><p>Time period</p></td><td><p>Total essential services funding<sup>2</sup> /£</p></td><td><p>Total national CPCF funding (essential and advanced services) less medicines margin/ £</p></td><td><p>Funding for essential services as a proportion of total national CPCF funding (essential and advanced services) less medicines margin/ %</p></td></tr><tr><td><p>2015/16</p></td><td><p>1,881,828,149</p></td><td><p>2,000,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2016/17</p></td><td><p>1,769,216,586</p></td><td><p>1,887,000,000</p></td><td><p>94</p></td></tr><tr><td><p>2017/18</p></td><td><p>1,668,141,583</p></td><td><p>1,792,000,000</p></td><td><p>93</p></td></tr></tbody></table><p><sup><br>2</sup>This comprises the fees and allowances paid under Part IIIA: Professional Fees (Pharmacy Contractors) and Part VIA: Payment for Essential Services (Pharmacy Contractors) of the Drug Tariff, and through the Quality Payment Scheme and Pharmacy Access Scheme. This does not include medicines margin.</p><p>Within the NHS Long Term Plan, Government has committed to expanding the number of pharmacists in Primary Care Networks. These pharmacists are well placed to work alongside the wider medical team to optimise the use of medicines, promote medicines adherence and improve the clinical and cost effectiveness of prescribed medications. Identifying and supporting patients on complex polypharmacy and those with long term conditions necessitating repeat prescriptions will form an important part of their role. Alongside this, in August 2018, NHS England, announced plans for a new pilot scheme, with investment of £1 million from the Pharmacy Integration Fund to develop system leadership within pharmacy across all settings. These pharmacy leaders will set the vision to systematically tackle medicines optimisation priorities for the local population within GP Network and Integrated Care System foot prints, further supporting medicines adherence, and in turn reducing medicines wastage.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219278 219279 219280 question first answered 14/02/2019 17:46:27 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

988864

registered interest
date	16/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to pulmonary rehabilitation.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	180099
answer	answer is ministerial correction date of answer 22/10/2018 answer text <p>Pulmonary rehabilitation is one of the most effective treatments for chronic lung disease. Respiratory care is one of the areas being considered as part of the National Health Service long-term plan currently in development and new guidelines from the National Institute for Health and Care Excellence are due to be published in December.</p><p> </p><p>The Department supports the NHS to increase access to pulmonary rehabilitation and improve the quality of care for people with long-term respiratory conditions through the following actions:</p><p> </p><p>- a national roll out of the RightCare programme by NHS England which directs clinical commissioning groups to offer pulmonary rehabilitation as part of an optimal pathway for COPD patients;</p><p>- the COPD best practice tariff encourages NHS providers to refer patients for pulmonary rehabilitation as a financial incentive;</p><p>- a pulmonary rehabilitation service accreditation programme run by the Royal College of Physicians.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 180100 question first answered 22/10/2018 16:24:49 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

988865

registered interest
date	16/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the World COPD Day on 21 November 2018, what steps his Department is taking to ensure the NHS long-term plan includes an expansion of pulmonary rehabilitation services.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	180100
answer	answer is ministerial correction date of answer 22/10/2018 answer text <p>Pulmonary rehabilitation is one of the most effective treatments for chronic lung disease. Respiratory care is one of the areas being considered as part of the National Health Service long-term plan currently in development and new guidelines from the National Institute for Health and Care Excellence are due to be published in December.</p><p> </p><p>The Department supports the NHS to increase access to pulmonary rehabilitation and improve the quality of care for people with long-term respiratory conditions through the following actions:</p><p> </p><p>- a national roll out of the RightCare programme by NHS England which directs clinical commissioning groups to offer pulmonary rehabilitation as part of an optimal pathway for COPD patients;</p><p>- the COPD best practice tariff encourages NHS providers to refer patients for pulmonary rehabilitation as a financial incentive;</p><p>- a pulmonary rehabilitation service accreditation programme run by the Royal College of Physicians.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 180099 question first answered 22/10/2018 16:24:49 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

926554

registered interest
date	18/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s single departmental plan, for what reason the intention to work with Public Health England to deliver the new Tobacco Control Plan under Objective 1.1 was removed in the update of 23 May 2018.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	154596
answer	answer is ministerial correction date of answer 21/06/2018 answer text <p>The Single Departmental Plan published on 23 May 2018 is a concise summary of the highest level objectives for the financial year 2018-19 rather than a comprehensive account of all the activities the Department is planning to undertake. The fact that a commitment or activity has not been included in the summary does not imply that there is no intention to work on it.</p><p> </p><p>The Government is continuing to reduce harm caused by tobacco. Last year we published a new tobacco control plan to build on that success and on 7 June 2018 we published a delivery plan setting out actions for meeting the aims of the tobacco control plan and how progress will be monitored. A copy of the delivery plan is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/tobacco-control-plan-delivery-plan-2017-to-2022" target="_blank">https://www.gov.uk/government/publications/tobacco-control-plan-delivery-plan-2017-to-2022</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/06/2018 16:03:19 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron